Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly Cash from Investing Activities of -$30080.0 for Q2 2026, up 49.19% year-over-year from -$20162.3 in Q2 2025, and down 67.11% quarter-over-quarter from -$18000.0 in Q4 2025.
Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Cash from Investing Activities for 3 consecutive years, with -$30080.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 49.19% year-over-year to -$30080.0; the TTM figure through May 2026 stood at -$65480.0 (up 36.57% YoY), while the FY2025 annual figure was -$92140.0, down 223.3% from the prior year.
- Cash from Investing Activities fell to -$30080.0 in Q2 2026 per SKYI's latest filing, from -$18000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$15540.0 in Q1 2025 and bottomed at -$59200.0 in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$28120.0 across 3 years, with a median of -$23250.0 in 2024.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 38.95% — and 2026, when it soared 49.19%.
- Sky Century Investment's Cash from Investing Activities stood at -$28500.0 in 2024, then jumped by 36.84% to -$18000.0 in 2025, then plunged by 67.11% to -$30080.0 in 2026.
- Business Quant data shows SKYI's Cash from Investing Activities at -$30080.0 in Q2 2026, -$18000.0 in Q4 2025, and -$17400.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -30,080.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -30,080.00 |
| May 31, 2026 | -30,080.00 |
| Nov 30, 2025 | -18,000.00 |
| Nov 30, 2025 | -18,000.00 |
| Aug 31, 2025 | -17,400.00 |
| Aug 31, 2025 | -17,400.00 |
| May 31, 2025 | -59,200.00 |
| May 31, 2025 | -59,200.00 |
| Feb 28, 2025 | -15,540.00 |
| Feb 28, 2025 | -15,540.00 |
| Aug 31, 2024 | -28,500.00 |
| Aug 31, 2024 | -28,500.00 |